Fundz

Dynamis Pharmaceuticals, Inc. reported raising $458,000 in an initial SEC Form D filing, from an offering of $458,000

PRIVATEAug 30, 2018

Amount Raised

$458,000

$458,000 sold, per SEC Form D (first sale Aug 30, 2018)

Round Type

Seed

JenkintownHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Dynamis Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Riparian Pharmaceuticals, Inc. raised $500K (Seed) on October 12, 2018.
  • MINDSCIENCES, INC. raised $2.1M (Seed) on October 12, 2018.
  • 7wV-EssCo, Inc. raised $6M on October 12, 2018.
  • Axe Compute Inc. raised $2M (Seed) on October 11, 2018.
  • VAPOTHERM INC raised $10M on October 11, 2018.
  • Propanc Biopharma raised $422K (Seed) on October 11, 2018.

Who to call at Dynamis Pharmaceuticals, Inc., and when

A new round usually means Dynamis Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dynamis Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dynamis Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dynamis Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dynamis Pharmaceuticals, Inc.

Location

261 OLD YORK ROAD

Jenkintown, Pennsylvania, United States

About

Dynamis Pharmaceuticals is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dynamis Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Dynamis Pharmaceuticals, Inc.'s next move

See what Strategic adds

Dynamis Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.